Eye Clinic Of Nd - Medicare in Bismarck, ND

Eye Clinic Of Nd is a medicare enrolled "Ophthalmology" provider in Bismarck, North Dakota. Their current practice location is 620 N 9th St, Bismarck, North Dakota. You can reach out to their office (for appointments etc.) via phone at (701) 255-4673.

Eye Clinic Of Nd is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Eye Clinic Of Nd is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1497853717.

Contact Information

Eye Clinic Of Nd
620 N 9th St,
Bismarck, ND 58501-4112
(701) 255-4673
(701) 255-4934



Healthcare Provider's Profile

Full NameEye Clinic Of Nd
TypeFacility
SpecialityOphthalmology
Location620 N 9th St, Bismarck, North Dakota
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1497853717
  • Provider Enumeration Date: 09/20/2006
  • Last Update Date: 03/26/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 3274511423
  • Enrollment ID: O20040713000712

Medical Identifiers

Medical identifiers for Eye Clinic Of Nd such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1497853717NPI-NPPES
202-001OtherNDBLUE SHIELD OF ND
013956MedicaidND
7779480MedicaidSD

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Secondary
207W00000XOphthalmology (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Eye Clinic Of Nd acts as a billing entity for following providers:
Provider NameMonte J Leidenix
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1104814425
PECOS PAC ID: 9335127588
Enrollment ID: I20040716000565

News Archive

Half of all Australians still believe a tan is healthy

New research showing half of all Australians still believe a tan is healthy has added to cancer experts' fears of a prolonged national skin cancer epidemic.

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases

Modern research is delving deep into the human genome to find the answers to medical mysteries and, hopefully, cures for the most deadly diseases. According to four new studies presented during the 46th Annual Meeting of the American Society of Hematology

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.

A protein that helps treat viruses can later interfere with lung tissue repair

Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body's immune response to a virus, can later interfere with the repair of lung tissue.

Read more Medical News

› Verified 9 days ago

Provider NameLucas Schnaidt
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1477114098
PECOS PAC ID: 4981063898
Enrollment ID: I20230710001585

News Archive

Half of all Australians still believe a tan is healthy

New research showing half of all Australians still believe a tan is healthy has added to cancer experts' fears of a prolonged national skin cancer epidemic.

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases

Modern research is delving deep into the human genome to find the answers to medical mysteries and, hopefully, cures for the most deadly diseases. According to four new studies presented during the 46th Annual Meeting of the American Society of Hematology

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.

A protein that helps treat viruses can later interfere with lung tissue repair

Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body's immune response to a virus, can later interfere with the repair of lung tissue.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Eye Clinic Of Nd is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Eye Clinic Of Nd
620 N 9th St,
Bismarck, ND 58501-4112

Ph: (701) 255-4673
Eye Clinic Of Nd
620 N 9th St,
Bismarck, ND 58501-4112

Ph: (701) 255-4673

News Archive

Half of all Australians still believe a tan is healthy

New research showing half of all Australians still believe a tan is healthy has added to cancer experts' fears of a prolonged national skin cancer epidemic.

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases

Modern research is delving deep into the human genome to find the answers to medical mysteries and, hopefully, cures for the most deadly diseases. According to four new studies presented during the 46th Annual Meeting of the American Society of Hematology

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.

A protein that helps treat viruses can later interfere with lung tissue repair

Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body's immune response to a virus, can later interfere with the repair of lung tissue.

Read more News

› Verified 9 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.